Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Ketamine for Treatment Resistant Late-Life Depression


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02556606

Organisation Name: VA Office of Research and Development

Overal Status: Active, not recruiting

Start Date: October 1, 2015

Last Update: October 8, 2020

Lead Sponsor: VA Office of Research and Development

Brief Summary: The purpose of this study is to examine the effectiveness of a single infusion of ketamine (KET), to determine which dose is optimal and lasts the longest, and to learn about how ketamine works in the body and brain in persons with late-life treatment resistant depression.

Conditions:
  • Treatment Resistant Depressive Disorder


Total execution time in seconds: 0.19669890403748